Barton joins NCQA as VP

Mary Barton, MD, MPP, will become the National Committee for Quality Assurance’s new vice president for performance measurement.

Barton comes to the National Committee for Quality Assurance (NCQA) from the Agency for Healthcare Research and Quality (AHRQ), where she was the scientific director of the U.S. Preventive Services Task Force (USPSTF). In that role, she provided oversight for the methodological, evidence review and recommendation-making work of the USPSTF.

Prior to joining AHRQ, she was an assistant professor at Harvard Medical School in Boston, where she performed clinical epidemiology and health services research related to cancer screening and prevention focusing on access, test performance and outcomes, the Washington, D.C.-based NCQA stated.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.